Fortrea sees growing early inclusion of China in global rare disease trials
FTRE•Fortrea says global sponsors are increasingly including China early in rare disease trials, where more than 20 million people are affected by rare diseases.
1. China in rare disease trials
Fortrea’s industry analysis says global sponsors are increasingly including China early in rare disease trials to accelerate recruitment and streamline development. It says China has more than 20 million people affected by rare diseases, and participation in Phase I or Phase II programs may reduce additional study requirements later in development.
